Companies: 10,795·Total market cap: $144.5T
Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

AXSMNASDAQHealthcare● Active
$237.77
+$5.45(+2.34%)
Market Cap$12.2B
P/E Ratio
52W High$242.41
52W Low$96.09
Overview

Axsome Therapeutics, Inc.(AXSM)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · AXSM · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.64B$0.39B$0.27B$0.05B$0.00B
Cost of Revenue$0.05B$0.03B$0.03B$0.01B$0.00B
Gross Profit$0.59B$0.35B$0.24B$0.04B$0.00B
Gross Margin %(computed)92.56%91.37%90.37%89.61%
Operating Expenses
R&D Expenses$0.18B$0.19B$0.10B$0.06B$0.06B
G&A Expenses$0.00B$0.31B$0.22B$0.00B$0.07B
Total Operating Expenses$0.76B$0.63B$0.48B$0.22B$0.12B
Operating Income($0.17B)($0.28B)($0.23B)($0.18B)($0.12B)
Operating Margin %(computed)-26.51%-72.74%-85.67%-359.33%
Interest Income$0.01B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.01B
Income Before Tax($0.18B)($0.29B)($0.24B)($0.19B)($0.13B)
Income Tax Expense($0.00B)$0.00B$0.00B$0.00B$0.00B
Net Income($0.18B)($0.29B)($0.24B)($0.19B)($0.13B)
Net Margin %(computed)-28.69%-74.47%-88.41%-373.99%
Per Share & EBITDA
EPS (Basic)$-3.68$-5.99$-5.27$-4.60$-3.47
Wtd Avg Shares0.05B0.05B0.05B0.04B0.04B
EBITDA($0.17B)($0.27B)($0.22B)($0.18B)($0.12B)
EBITDA Margin %(computed)-26.32%-70.68%-83.15%-350.53%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Axsome Therapeutics, Inc.

关于Axsome Therapeutics, Inc.(AXSM)损益表

Axsome Therapeutics, Inc.(AXSM)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,AXSM实现营收$0.64B,毛利润$0.59B(毛利率92.56%),净利润($0.18B)(净利率-28.69%)。

常见问题

AXSM · 4 问

Axsome Therapeutics, Inc.(AXSM)2025财年营收为$0.64B,同比up65.5%。

AXSM revenueAXSM salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08